Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CorNeat EverPatch - a First-In-Man Clinical Study for Demonstrating the Safety of a Synthetic Tissue Substitute for Concealment of Artificial Implants and Glaucoma Tube Shunts

NCT04037917 is registered in ClinicalTrials.gov with CorNeat Vision Ltd. as lead sponsor.

NCT NCT04037917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04037917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CorNeat EverPatch - a First-In-Man Clinical Study for Demonstrating the Safety of a Synthetic Tissue Substitute for Concealment of Artificial Implants and Glaucoma Tube Shunts
Lead sponsor
CorNeat Vision Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
December 11, 2020
Completion date
July 1, 2023
Enrollment
28 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma eye, tissue breakdown